News

Digital RESI September 2020 Innovation Challenge Winner

InvivoSciences participated in Life Science Nation’s Digital Redefining Early Stage Investments (RESI) September Conference this past week. We are excited to announce that we won the second place as one of the Top 3 Winners of the Innovation Challenge Competition. Through the challenge, our company had a dedicated page featuring a virtual poster, short pitch, and…
Read more

RESI Conference

InvivoSciences has been selected to participate and present at the Digital RESI September 2020 conference as an NIH delegated company; we have also been selected to participate in their VC partnering program. Let’s meet at RESI!

InvivoSciences Selected as MassChallenge Finalist

InvivoSciences has been selected as one of the finalist among thousands of global entries to participate in MassChallenge Boston’s 2020 Accelerator. Learn more about MassChallenge Boston’s 2020 program and see the rest of the cohort here. About MassChallenge MassChallenge is a global network of zero-equity startup accelerators. Headquartered in the United States with locations in…
Read more

Global Health and Pharma Award

Invivosciences, Inc has been honored with Global Health and Pharma’s 2020 Biotechnology Award for Best Tissue-Based Assay R&D Engineering Company. We would like to graciously accept this award. And thank GHP for their selection.

COVIDxNow

Invivosciences, Inc. is honored to work with COVID-19 Task Force to be part of solutions. We are dedicated to innovate and support researchers, medical teams and drug developers world-wide by providing uninterrupted contract research services. Learn more about the COVID-19 Task Force here.

Bio 2020

InvivoSciences has been given the honor to attend and present at the Bio 2020 Annual Meeting in San Diego, California from June 8-11, 2020. InvivoSciences is selected to participate under NIH Innovation Zone and will deliver a company presentation.  Learn more about BIO Digital here.

Brava Magazine Feature

InvivoSciences was recently featured in the February 2020 issue of Brava Magazine. You can read the article below. Previous Next

Welcome New Business Adviser Member, Dr. Lenka Fedorkova

Dr. Lenka Fedorkova InvivoSciences, Inc. is delighted to announce the joining of Dr. Fedorkova to the business team as Strategic Adviser. She is currently CEO/ Founder of bioPrime, LLC, Director Corporate Development at AfaSci Research Laboratories, Inc., and Board Member for Yale Entrepreneurial Institute. She was formerly Executive Manager of SBIR/STTR Programs at the National…
Read more

Join us at Washington DC

Our collaboration with Nihon Kohden and Tokyo Women’s Medical University is presented.